Cost-effectiveness of Brentuximab Vedotin in Treating Increased Risk of Relapse/progression of Classical Hodgkin Lymphoma Patients Post Autologous Stem Cell Transplant
Journal of Health and Development Studies（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要